CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

The association between body mass index and obesity with survival in pulmonary arterial hypertension Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Circulating Plasma microRNAs In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Update on chronic thromboembolic pulmonary hypertension rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial

Clinical Trial2016 Dec 20;8(33):54106-54114.

JOURNAL:Oncotarget. Article Link

Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension

Chen SL,Stone GW, Zhang H et al. Keywords: clinical worse event; pericardial effusion; pulmonary arterial hypertension; pulmonary artery denervation; rehospitalization

Abstract